Article · 9 Oct 2023
Conference abstractPublished 15 Aug 2011
Beta-glucans as anticancer agents
Department of Medicine, University of California-Irvine, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pattern-recognition receptors (PRRs) detect molecular signatures of microbes and initiate immune responses to infection. Immune responses generated by prototypical PRRs such as Toll-like receptors (TLRs) have been widely investigated. In contrast, the immune responses initiated by other classes of putative PRRs remain ill defined. C-type lectins are a class of PRRs that recognize carbohydrate structures which are often part of microbial pathogens. Dectin-1 is a C-type lectin receptor present on dendritic cells that recognizes fungal Ã?²-glucans. Our investigations suggest that Dectin-1 is not just an antigen uptake receptor but also a modulator or initiator of adaptive immune responses. Human dendritic cells stimulated with Curdlan, Dectin-1 agonist prime CD4 Th17 responses via IL-23 production. Furthermore, these CD4 T cells induce differentiation of B cells to secrete IgG and IgA. More importantly; these dectin-1 stimulated dendritic cells promote the expansion and differentiation of granzyme B expressing cytotoxic T lymphocyte that display high cytolytic activity against target tumor cells in vitro. The capacity of Curdlan-stimulated human DCs to induce differentiation of these cells makes them attractive target for manipulations in clinic against cancer.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 1 Sep 2022
Undenatured Beta-Glucan and Improvement in Quality of Life in Humans
Mini review · 31 Mar 2022
Benefits for Post Prandial Glucose, Lipid Metabolism, and Immune Modulation: A Mini-Review on Barley Beta-Glucan
Conference abstract · 2020
Beta-Glucan ��? promising candidate for vaccines and drug delivery
Conference abstract · 24 Oct 2018
Efficacy of beta-glucans from barley and maintenance of normal blood LDL-cholesterol concentrations: A study case study in Ghana
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Anshu Agrawal”
- BylineArticles whose byline prints “Sudhanshu Agrawal”
- BylineArticles whose byline prints “Sudhir Gupta”

